相关实验视频

Updated: Jun 10, 2025

Tracing Gene Expression Through Detection of β-galactosidase Activity in Whole Mouse Embryos

Tracing Gene Expression Through Detection of β-galactosidase Activity in Whole Mouse Embryos

Published on: June 26, 2018

向AGAT基因表达 - 一种用于治疗GAMT缺乏症的药物查方法

Ilona Tkachyova¹, Michael B Tropak¹, Alex Lee^1,2

¹Genetics and Genome Biology, The Hospital for Sick Children, Toronto, ON, Canada.

Expert opinion on drug discovery

|October 15, 2024

概括

研究人员选了6000种药物,以寻找L-氨酸:糖氨酸氨基转移酶 (AGAT) 的转录抑制剂,以治疗瓜尼迪诺酸甲基转移酶 (GAMT) 缺乏症. 没有任何被测试的候选药物显示出有效性,这表明这种方法可能具有风险.

科学领域:

生物化学生物化学
药理学药理学是指药理学的学科.
遗传学是一个遗传学.

背景情况:

瓜尼迪诺酸甲基转移酶 (GAMT) 缺乏症是一种罕见的代谢障碍.
在GAMT缺乏症中,瓜尼迪诺酸盐 (GAA) 水平升高可能导致神经功能障碍.
准L-氨酸:糖氨酸胺转移酶 (AGAT) 以减少GAA形成是一种潜在的治疗策略.

研究的目的:

为了识别能够转录抑制AGAT基因表达的重用药物.
在GAMT缺乏的细胞模型中评估潜在的AGAT抑制剂的疗效.

主要方法:

使用HeLa细胞系与AGAT促进剂-化酶记者对6000种化合物的高含量选.
根据剂量反应,毒性和配方,对候选药物的二次查和评估.
在HAP1和RH30细胞系中进行验证,包括具有内源AGAT-Nanoluc报告员的GAMT缺乏的RH30模型.

主要成果:

从最初的药物选中确定了43种AGAT表达抑制剂和34种诱导剂.
经过严格的淘汰后,七名候选人进行了进一步评估.
在7种被选中的药物中,没有一种在GAMT缺陷的细胞模型中显示出有效性.

结论:

通过转录抑制AGAT重定位药物是治疗GAMT缺乏症的一个具有挑战性的方法.
选择合适的查模型对于识别有效的基因抑制药物至关重要.
基因调节药物的潜在非向效应以及难以找到选择性AGAT抑制剂表明,药理性基因抑制可能是一种危险的治疗策略.

关键词:

在AGAT基因抑制过程中,AGAT基因被抑制.这是GAMT缺陷的缺陷.HAP1 AGAT基因 NLuc 记者融合基因希拉 AGAT 促进者 FLuc 记者细胞药物查对药物进行查.

更多相关视频

Author Spotlight: Finding New Therapeutic Targets for Malignant Peripheral Nerve Sheath Tumor Through Genome-Scale shRNA Screens

Author Spotlight: Finding New Therapeutic Targets for Malignant Peripheral Nerve Sheath Tumor Through Genome-Scale shRNA Screens

Published on: August 25, 2023

Removal of an Internal Translational Start Site from mRNA While Retaining Expression of the Full-Length Protein

Removal of an Internal Translational Start Site from mRNA While Retaining Expression of the Full-Length Protein

Published on: March 16, 2022

相关概念视频

Gene Therapy

Gene Therapy

Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be...

Genetic Screens

Genetic Screens

Genetic screens are tools used to identify genes and mutations responsible for phenotypes of interest. Genetic screens help identify individuals or a group of people at risk of developing genetic diseases and help them with early intervention, targeted therapy, and reproductive options.
Forward genetic screens
Forward or “classical” genetic screens involve creating random mutations in an organism’s DNA using radiation, mutagens, or insertion of additional bases, which...

In-vitro Mutagenesis

In-vitro Mutagenesis

To learn more about the function of a gene, researchers can observe what happens when the gene is inactivated or “knocked out,” by creating genetically engineered knockout animals. Knockout mice have been particularly useful as models for human diseases such as cancer, Parkinson’s disease, and diabetes.